It has been a mixed year for Rani Therapeutics Holdings, Inc. insiders: $1.3 million bought by two people and $15.7 million sold by three, so more selling than buying overall.
Biggest single buyer: IMRAN MIR A, Director, with roughly $1.3 million. C-suite participation is part of the picture here.
Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. 67 investment managers listed RANI in their latest 13F filings (Q2 2026); more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMRAN MIR A | Director | Buy | 36,000 | $0.69 | $25K | SEC |
| Jul 21, 2026 | Javadi Alireza | Executive Officer | Sell | 386 | $0.78 | $301 | SEC |
| Jul 21, 2026 | Imran Talat | CEO | Buy | 35,000 | $0.72 | $25K | SEC |
| Jul 21, 2026 | Imran Talat | CEO | Sell | 8,014 | $1.41 | $11K | SEC |
| Oct 27, 2025 | IMRAN MIR A | Director | Buy | 2,083,334 | $0.61 | $1.3M | SEC |
| Oct 22, 2025 | South Cone Investments Limited Partnership | 10% Owner | Sell | 4,000,000 | $2.77 | $11.1M | SEC |
| Oct 22, 2025 | South Cone Investments Limited Partnership | 10% Owner | Sell | 1,923,000 | $2.41 | $4.6M | SEC |
| Dec 16, 2024 | McKinley Kate | Executive Officer | Buy | 17,960 | $1.67 | $30K | SEC |
| Dec 10, 2024 | Imran Talat | CEO | Buy | 10,296 | $1.94 | $20K | SEC |
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 3,305,622 | $2.55 | $8.4M | SEC |
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 523,738 | $3.26 | $1.7M | SEC |
| Dec 8, 2023 | Aequanimitas Limited Partnership | 10% Owner | Sell | 5,265,165 | $2.01 | $10.6M | SEC |
| Dec 8, 2023 | South Cone Investments Limited Partnership | 10% Owner | Buy | 5,265,165 | $2.01 | $10.6M | SEC |
| Dec 7, 2023 | Imran Talat | CEO | Buy | 10,000 | $2.27 | $23K | SEC |
| Dec 6, 2023 | Imran Talat | CEO | Buy | 5,000 | $2.57 | $13K | SEC |
In the last 12 months Rani Therapeutics Holdings, Inc. insiders made open-market purchases worth about $1.3 million and sales worth about $15.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in RANI was filed on 2026-07-23.
67 investment managers reported holding RANI in SEC Form 13F filings for Q2 2026.
No congressional trades in RANI were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).